Precision Medicine in Cancer Therapy: Targeting HPV16 and Neoantigens with pDNA and mRNA Platforms
Time: 11:45 am
day: Conference Day One
Details:
- Highlighting the targeting of HPV16 and neoantigens to enhance immune response in precision oncology for HPV-related and other cancers
- Demonstrating the versatility and effectiveness of pDNA and mRNA platforms in developing and validating cancer immunotherapies
